Recommended Free Tools
The reliable way to compare health-insurance stocks is to normalize business mix, medical-cost ratios, operating margins, membership trends, government-program exposure, cash flow, regulated capital and valuation on the same dates. A single medical loss ratio (MLR), revenue-growth figure or quarter-end share price can be misleading because insurers sell different products and report ratios with different definitions.
Why headline numbers and one-quarter rankings fail
Health insurers are combinations of businesses rather than interchangeable versions of the same company. One group may earn most of its profit from employer plans, another from Medicare Advantage, another from Medicaid, and another from pharmacy, care-delivery or administrative-services operations. Their claim patterns, payment formulas, capital requirements and accounting denominators differ.
As an Amazon Associate I earn from qualifying purchases.
Start with a like-for-like comparison: the same reporting period, the same level of consolidation, the same definition of medical costs and premiums, and the same treatment of unusual items. Then examine several years or quarters. A lower reported MLR is not automatically better if it reflects a favorable reserve release, a temporary membership mix or an insurer that retains less underwriting risk.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →As a market context, the National Association of Insurance Commissioners (NAIC) reported that the aggregate US health-insurance combined ratio reached 101% in 2025 and the aggregate loss ratio was 90.3%. The industry recorded an $8.1 billion net underwriting loss but remained profitable because investment income helped offset it. The sector’s profit margin fell from 0.8% in 2024 to 0.4% in 2025. These are industry aggregates, not forecasts for any individual company.
#1 Best Overall
1. Map each company’s business mix before comparing ratios
Read the latest annual report and quarterly filing before opening a valuation screen. Build a simple map of revenue, operating income and members by product and service line. At minimum, identify commercial risk plans, Medicare Advantage and Part D, Medicaid, pharmacy services, care delivery and administrative-services-only contracts.
Commercial and employer coverage
Commercial plans generally price against employer-group demographics, negotiated provider rates and utilization. Membership can be relatively stable, but competition and employer switching can pressure premiums. Administrative-services-only contracts may generate fees without putting the insurer at full medical-claim risk, so fee revenue should not be treated as premium underwriting.
Medicare Advantage and Part D
Medicare Advantage and prescription-drug plans are heavily influenced by federal benchmarks, risk adjustment, star ratings, quality bonuses, coding rules and annual bid cycles. A company with a high Medicare concentration can show strong growth while facing greater sensitivity to a single payment regime.
Medicaid
Medicaid economics depend on state contracts, eligibility redeterminations, acuity, rate updates and supplemental payments. Membership can change rapidly when states resume eligibility reviews. Compare the states and products involved rather than assuming that every Medicaid enrollee has the same margin profile.
Services, pharmacy and care delivery
Pharmacy-benefit, provider, data, consulting and care-delivery operations may earn revenue without a conventional premium denominator. Their margins and cash-conversion patterns differ from insurance underwriting. Consolidated earnings therefore cannot be interpreted by subtracting one group-level MLR from 100%.
| Comparison axis | What to inspect | How to avoid a misleading comparison |
|---|---|---|
| Business mix | Premiums, members and operating profit by commercial, Medicare, Medicaid and services | Use the same period and segment level; revenue share is not profit share. |
| Underwriting exposure | Which products carry medical-claim risk and which earn fees | Separate risk-bearing premiums from administrative-services revenue. |
| Government concentration | Share of premiums tied to CMS or state programs | Identify the subsidiaries and products carrying each policy exposure. |
Two published figures illustrate why denominators matter. Humana reported that 82.6% of its Insurance segment premiums and services revenue came from Medicare in 2025. That is a segment revenue share, not a share of consolidated group revenue. UnitedHealth Group reported that 44% of consolidated revenue came from CMS premiums in 2025, most generated by Medicare & Retirement. Those percentages are not directly comparable because one is a segment measure and the other is a consolidated measure.
Rank #2
- Comes with secure packaging
- Easy to read text
- It can be a gift option
2. Understand MLR, MCR and benefit ratios
A medical loss ratio, medical care ratio or benefit ratio generally measures medical claims or benefit expense divided by premium revenue under the issuer’s definition:
Medical ratio = medical costs ÷ premium revenue × 100
The labels are not interchangeable without reading the footnote. Companies may include pharmacy costs, quality-related adjustments, premium deficiency reserves or other items differently. Confirm the numerator, denominator, consolidation level and whether the figure is reported before or after reinsurance.
Why the ratio is not a profit margin
If an insurer reports an 88% medical ratio, the remaining 12 percentage points are not profit. Administrative salaries, technology, commissions, taxes, interest, depreciation, amortization, acquisition costs, non-insurance businesses and corporate expenses still have to be paid. Compare the medical ratio with administrative or operating-expense ratios and with GAAP operating margin.
Use both reported and adjusted earnings, but reconcile them. An adjusted operating-income figure can exclude restructuring, amortization or other items that are economically relevant. The filing’s reconciliation shows what was removed and whether the item is genuinely unusual.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Cross-company quarterly context
Oliver Wyman’s 2026 analysis of 2025 results reported these fourth-quarter medical loss ratios: Aetna 94.8%, Elevance 93.5%, UnitedHealthcare 92.4% and Cigna 88.4%. The analysis cautioned that fourth-quarter seasonality affects the comparison. Treat the figures as context, verify each company’s filing definition and do not use them as a buy ranking.
| Issuer or unit | Period | Reported ratio | Important qualification |
|---|---|---|---|
| Humana consolidated | 2025 | 90.2% benefit ratio | Included about 80 basis points of favorable prior-period medical-claims reserve development. |
| Humana consolidated | Q2 2026 / first half 2026 | 91.1% / 90.2% | Year-over-year movement was partly tied to member mix and reserve development. |
| Molina Healthcare | 2025 | 91.7% MCR | Up from 89.1% in 2024, primarily because utilization exceeded expectations and member acuity shifted. |
| CVS Health | Q2 2026 | 87.4% medical benefit ratio | Improvement reflected better underlying Government performance and the absence of a $471 million prior-year premium-deficiency reserve. |
3. Read operating margins alongside medical costs
After calculating the medical ratio, examine operating income and operating margin for the same segment and period. A company can have a favorable medical ratio but a weak operating margin if administrative costs, interest or non-insurance losses rise. Conversely, a higher medical ratio can coexist with stable earnings when pricing, fee income or investment income offsets claims.
Molina’s 2025 results show why this two-step check matters: its MCR rose to 91.7% from 89.1% in 2024, while operating income fell to $781 million from $1.707 billion. The filing attributes the MCR change mainly to higher-than-expected utilization and a shift in member acuity. Do not infer that every two-point ratio movement has the same earnings effect; the premium base, product mix and expense structure determine the dollars involved.
4. Test whether a trend is structural or temporary
Reserve development
Insurers estimate claims before all bills arrive. When later claims are lower than expected, favorable prior-period development reduces the current ratio; when they are higher, unfavorable development increases it. Show current-period claims separately from prior-period reserve movement whenever the filing provides that bridge.
Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallHumana’s 90.2% 2025 consolidated benefit ratio included about 80 basis points of favorable prior-period development. That benefit should not be projected indefinitely. CVS’s 87.4% second-quarter 2026 ratio likewise benefited from the absence of a $471 million premium-deficiency reserve recorded in the prior year. The correct question is what the ratio would have been without each exceptional item.
Seasonality and utilization
Medical use changes through the year. Flu seasons, deferred procedures, catastrophic events, drug trends and the timing of annual wellness visits can move quarterly claims. Compare the same quarter year over year and use trailing-twelve-month or full-year figures when possible. A fourth-quarter comparison across companies is especially sensitive to seasonal patterns.
Membership mix and acuity
New members, product exits, geographic changes and eligibility redeterminations can change average risk. A growing book may initially contain members with different acuity from the established book. Ask whether pricing was set before the latest utilization information and whether the company changed benefits or networks.
Management explanations
Read the earnings release, filing and conference-call reconciliation for rate increases, trend assumptions, risk adjustment, reserve development and one-time items. Treat a ratio change as structural only when the explanation, membership data and several periods point in the same direction.
5. Evaluate government-program economics explicitly
Government exposure is not a single risk factor. For Medicare Advantage, review benchmark-rate updates, risk-adjustment model changes, coding intensity, star ratings, quality bonuses, benefit reductions and audit activity. UnitedHealth said its 2025 filing that continued funding pressure and higher care patterns affected its 2026 Medicare Advantage outlook; check the current filing for the company’s exact assumptions.
For Part D, inspect plan redesign and rule changes that alter the division of drug costs among plans, manufacturers and the government. For Medicaid, track state rate adequacy, contract renewals, redeterminations, acuity and supplemental payments. A company’s consolidated government share can hide concentration in a few states or subsidiaries.
Commercial insurers must also comply with Affordable Care Act minimum-loss-ratio rules. If spending on clinical care and quality improvement falls below the applicable threshold, rebates may be owed. A rebate can reduce current revenue even when claims are low, so read the filing’s treatment of rebate accruals.
6. Separate membership growth from profitable growth
Collect enrollment by product, geography and quarter, then compare it with premium growth and operating income. Growth is valuable only when rates cover expected claims and expenses. Rapid enrollment after a contract win can dilute margins if pricing lags utilization; a membership decline can improve margins if an insurer exits underpriced products.
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Elevance Health reported 44.9 million medical members on June 30, 2026. That scale provides context for bargaining power and fixed-cost absorption, but enrollment alone says nothing about underwriting quality or profitability. Look for retention, risk mix, premium per member, medical cost per member and operating income per member where disclosed.
Best Value
7. Check cash flow, debt and regulated capital
Operating cash flow
Profit does not guarantee cash. Claims paid, premium receivables, risk-adjustment settlements and reserve movements can create a gap between earnings and operating cash flow. NAIC reported adjusted operating cash flow of negative $3.4 billion for the aggregate health-insurance industry in 2025. Investigate whether a company’s cash result reflects timing or a persistent mismatch between collections and claims.
Debt and interest burden
Compare total debt, maturities, floating-rate exposure, interest expense and the ratio of operating income to interest. Services acquisitions can add debt without increasing regulated insurance capital. Include lease obligations and contingent liabilities when they are material.
Liquidity and insurance-subsidiary capital
Parent-company cash cannot automatically be transferred from a regulated insurer. Review holding-company liquidity, dividend restrictions, statutory capital and risk-based-capital (RBC) disclosures. The NAIC Financial Data Repository covers ten years of annual and quarterly statutory data, more than 98% of US premiums and over 4,500 insurers, and supports financial-ratio and RBC analysis.
For industry context, NAIC reported aggregate capital and surplus of $223.9 billion in 2025, up 4.9% from 2024, excluding affiliated amounts. Compare a company’s statutory surplus and RBC trend with its premium growth and acquisition plans rather than treating a large absolute surplus as proof of safety.
8. Normalize valuation before comparing prices
Choose one valuation date and use the same share-price close, fiscal period and forecast convention for every company. Useful measures include trailing P/E, forward P/E, free-cash-flow yield and enterprise value to operating income. Normalize restructuring charges, amortization, reserve releases and other unusual items before calculating earnings-based multiples.
Pair valuation with expected growth and risk. A lower P/E may reflect concentrated Medicare exposure, inadequate pricing, weak capital or a falling earnings base. A higher multiple may reflect steadier commercial membership, diversified services or stronger cash conversion. Include dividend policy, buybacks, debt and regulated-capital needs in the valuation narrative.
No same-date, normalized valuation ranking is established here, so it would be misleading to name a cheapest or best stock. Build the table from current filings and market data immediately before making an investment decision.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problemsA repeatable comparison worksheet
- Set the date. Record each company’s latest annual and quarterly filing date and the share price used.
- Map exposure. Enter premium, revenue, members and operating profit for commercial, Medicare, Medicaid and services businesses.
- Copy definitions. Transcribe each issuer’s MLR, MCR or benefit-ratio numerator and denominator from the footnote.
- Calculate trends. Build at least eight quarters when available, flagging reserve development, seasonality and membership changes.
- Bridge to earnings. Place medical costs, administrative expenses, operating income, interest, taxes and non-insurance results on one schedule.
- Stress government assumptions. Note CMS and state-rate changes, risk adjustment, quality bonuses, rebates, audits and contract renewals.
- Check cash and capital. Compare operating cash flow, debt maturities, liquidity, statutory surplus and RBC measures.
- Value consistently. Use identical dates and normalized earnings for P/E, free-cash-flow yield or enterprise-value measures.
- Write the risk case. State which assumption would most damage earnings: utilization, pricing, policy, reserve development, membership or financing.
Common comparison mistakes
- Calling 100% minus MLR a profit margin. Administrative costs and other businesses are excluded.
- Mixing segment and consolidated denominators. Humana’s Medicare percentage and UnitedHealth’s CMS percentage measure different scopes.
- Projecting a reserve release. Favorable prior-period development is not recurring premium economics.
- Comparing unmatched periods. A fourth-quarter ratio versus a full-year ratio embeds seasonality.
- Ignoring product exits. Shrinking membership can raise margins if unprofitable cohorts were discontinued.
- Equating scale with quality. Millions of members do not establish adequate pricing or good claims control.
- Using parent cash as insurer capital. Statutory subsidiaries face dividend and capital restrictions.
- Ranking on an unverified screen. Different adjustments and forecast dates can reverse a valuation conclusion.
Putting the evidence together
A defensible comparison ends with a normalized earnings view, not a single ratio. Explain how each company’s mix affects claims risk, how current medical trends differ from reserve development, whether membership growth is priced adequately, how government rules affect the next planning year, and whether cash and statutory capital support the strategy. Only after those checks should a valuation multiple be interpreted. This framework is educational, not personalized investment advice; verify the latest filings and market prices before acting.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
